🔎 Trials Near Me

Utama › Obesiti › Oklahoma › Oklahoma City

Kajian klinikal Obesiti di Oklahoma City, OK

10 kajian untuk Obesiti sedang mencari peserta di lokasi dalam dan sekitar Oklahoma City (dalam lingkungan kira-kira 30 batu). Buka kajian untuk melihat siapa yang layak menyertai dan cara menghubungi pasukan kajian.

Teks kajian rasmi (Bahasa Inggeris)

Mengambil peserta untuk kajian di sini? Paparkan di bahagian atas halaman ini — $99 selama 30 hari →

A Research Study on How Well Cagrilintide and CagriSema Work in Children and Adolescents With Excess Body Weight

Mengambil pesertaFasa 3
  • Children's Physicians OU, Oklahoma City
Umur 8 hingga 18 · Semua jantina · Dikemas kini 30 Sep 2026 · NCT07253285

Study to Assess the Effect and Safety of ALV-100 on Maintenance of Weight Loss

Mengambil pesertaFasa 2
  • Lynn Health Science Institute, Oklahoma City
Umur 18 hingga 75 · Semua jantina · Dikemas kini 28 Sep 2026 · NCT07837973

A Platform Trial for Pediatric Participants With Obesity or Overweight (LY900040)

Mengambil pesertaFasa 3
  • University of Oklahoma Health Sciences Center, Oklahoma City
Umur 6 hingga 17 · Semua jantina · Dikemas kini 24 Sep 2026 · NCT06672549

A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes

Mengambil pesertaFasa 3
  • AURORA-2 Clinical Site, Oklahoma City
Umur 18 ke atas · Semua jantina · Dikemas kini 16 Sep 2026 · NCT07743450

Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity

Mengambil pesertaFasa 3
  • South Oklahoma Heart Research, Oklahoma City
Umur 18 hingga 99 · Semua jantina · Dikemas kini 16 Sep 2026 · NCT07037459

A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 Diabetes

Mengambil pesertaFasa 3
  • Lynn Health Science Institute, Oklahoma City
Umur 18 ke atas · Semua jantina · Dikemas kini 14 Sep 2026 · NCT07351058

A Study of Aleniglipron in Adults With Obesity or Overweight and Type 2 Diabetes Mellitus (ACCOMPLISH-2)

Mengambil pesertaFasa 3Sukarelawan sihat dialu-alukan
  • ACCOMPLISH-2 Research Site, Yukon · 14 mi jauh
Umur 18 hingga 79 · Semua jantina · Dikemas kini 11 Sep 2026 · NCT07654374

Efficacy, Safety and Tolerability of Switching From Glucagon-like Peptide-1 Receptor Agonists (GLP-1RA) to Maridebart Cafraglutide in Adults With Obesity or Overweight (MARITIME-SWITCH)

Mengambil pesertaFasa 3
  • Lynn Health Science Institute, Oklahoma City
Umur 18 hingga 99 · Semua jantina · Dikemas kini 27 Ogo 2026 · NCT07575399

A Study to See How Safe and Effective Alirocumab is When Given Weekly to Adult Participants Who Have Hypercholesterolemia

Mengambil pesertaFasa 2
  • Lynn Health Science Institute, Oklahoma City
Umur 18 hingga 80 · Semua jantina · Dikemas kini 22 Jul 2026 · NCT07477704

Uterine Preservation Via Lifestyle Transformation

Mengambil pesertaFasa 2
  • University of Oklahoma, Oklahoma City
Umur 18 ke atas · Wanita · Dikemas kini 20 Jan 2026 · NCT05903131

Kajian Obesiti di bandar lain

Kajian lain di Oklahoma City

Daripada ClinicalTrials.gov, data diperoleh pada 5 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.